CJC-1295 / Ipamorelin 5MG

CJC-1295 / Ipamorelin 5MG

$76.00

For Research Use Only — Not for Human or Veterinary Consumption. Sold by Longevra Research LLC for laboratory use only. Not approved by the FDA. Not intended to diagnose, treat, cure, prevent, or mitigate any disease.

This is a blend of two different peptides: CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH); and Ipamorelin, a five-amino-acid peptide that binds the ghrelin receptor (GHS-R). They sit on different parts of the somatotropic axis. Labs use the blend to study how dual-receptor engagement of the GH axis differs from either peptide alone.

What ships: 5MG per vial · ≥99% HPLC-verified purity · MS-confirmed identity · batch-specific Certificate of Analysis.

Bulk pricing — auto-applied at checkout
QuantityYou savePer unit
3+5%$72.20
5+10%$68.40
10+15%$64.60
Download Certificate of Analysis

Description

This blend co-formulates CJC-1295 without DAC, a synthetic GHRH analog, with ipamorelin, a synthetic pentapeptide ghrelin receptor agonist. The 5 mg vial is intended for laboratory workflows where smaller working quantities are required, such as pilot in vitro studies or limited rodent pharmacology research touching the growth hormone secretagogue axis.

Research Context

Preclinical investigations have studied the combined application of GHRH analogs and ghrelin receptor agonists for their convergent effect on growth hormone (GH) secretion in rodent and in vitro pituitary models. CJC-1295 binds the GHRH receptor, while ipamorelin engages the growth hormone secretagogue receptor (GHS-R1a). Researchers have used the combination as a tool for examining receptor-level synergy at the somatotroph and resulting amplitude and pattern of GH release. Ipamorelin’s reported selectivity, with minimal off-target activity at HPA axis or prolactin pathways in preclinical literature, has been a frequent reason cited for its inclusion as a comparator compound in secretagogue research.

Reconstitution & Storage

  • Recommended reconstitution: 2 mL bacteriostatic water per 5 mg vial
  • Storage: Lyophilized: 2-8°C (refrigerated), long-term -20°C. Reconstituted: 2-8°C, use within 28 days.
  • Stability: Avoid freeze-thaw cycles. Protect from light.

Quality Specifications

Parameter Specification
Purity ≥99% (HPLC)
Identity Confirmed by mass spectrometry
Form Lyophilized powder
Vial size 5 mg (blend)
COA Included with order

Research Use Only Disclaimer

This product is sold strictly for laboratory and scientific research purposes. Not for human consumption, ingestion, or administration. Not intended to diagnose, treat, cure, or prevent any disease. Not approved by the FDA for any clinical use.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 / Ipamorelin 5MG”

Your email address will not be published. Required fields are marked *